GlassScriptPhysician profile
Patrick J Cogley
NPI 1417941717
$1,403.59
in general payments reported to CMS, 2019-2025
16 companies · $740 in 2025
The $740 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $127 · 2024: $537 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $472.64 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $163.54 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $145.95 | 2023-2025 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $125.68 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $101.18 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.92 | 2023-2025 | Jardiance |
| Sanofi Pasteur INC. | $58.33 | 2025 | |
| Astellas Pharma US INC | $47.62 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $36.50 | 2024-2025 | Gardasil 9, Capvaxive, Dificid |
| Exact Sciences Corporation | $32.82 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.82 | 2024-2025 | Xifaxan, Trulance |
| Abbvie INC. | $29.07 | 2023-2025 | Vraylar |
| Abiomed | $24.83 | 2024 | Impella |
| Lundbeck LLC | $16.97 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $15.26 | 2023 | Shingrix, Arexvy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.46 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Cogley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.